Mycosis fungoides. Hematologic findings and terminal course.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001856:Bone Marrow Examination; D004802:Eosinophilia / Q000209:etiology; D005260:Female; D006689:Hodgkin Disease / Q000473:pathology; D006801:Humans; D007945:Leukemia, Lymphoid / Q000473:pathology; D007951:Leukemia, Myeloid / Q000473:pathology; D007964:Leukocytosis / Q000209:etiology; D007970:Leukopenia / Q000209:etiology; D008218:Lymphocytosis / Q000209:etiology; D008223:Lymphoma / Q000473:pathology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000473:pathology; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000097:blood* / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D011379:Prognosis
D000970:Antineoplastic Agents